HR Execs on the Move

Aerie Pharmaceuticals

www.aeriepharma.com

 
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals discovers, develops, and commercializes first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.aeriepharma.com
  • 4301 Emperor Boulevard Suite 400
    Durham, NC USA 27703
  • Phone: 919.237.5300

Executives

Name Title Contact Details
Stuart Williams
Director, R&D Preclinical Programs Profile
Richard Rubino
Chief Financial Officer Profile
Kathleen McGinley
Vice President Human Resources And Corporate Services Profile

Similar Companies

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.

Glacier County EMS

Glacier County EMS is a Cut Bank, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

University of Illinois Med Center

University of Illinois Med Center is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ontario Public Health Association

Ontario Public Health Association is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Eastern Ct Health Network

Eastern Ct Health Network is a Manchester, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.